Daniel Grosslight
Stock Analyst at Citigroup
(1.12)
# 3,564
Out of 4,761 analysts
105
Total ratings
33.33%
Success rate
-15.94%
Average return
Main Sectors:
Stocks Rated by Daniel Grosslight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Neutral | $120 → $129 | $127.06 | +1.53% | 5 | Jan 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $21 → $18 | $10.43 | +72.58% | 4 | Jan 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Buy | $7 → $6.25 | $4.81 | +29.94% | 7 | Jan 10, 2025 | |
| HCAT Health Catalyst | Maintains: Buy | $11 → $10 | $5.23 | +91.20% | 8 | Jan 10, 2025 | |
| MCK McKesson | Maintains: Buy | $713 → $677 | $597.71 | +13.27% | 7 | Jan 10, 2025 | |
| MPLN MultiPlan | Maintains: Neutral | $10 → $13 | $29.28 | -57.31% | 9 | Jan 10, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $35 | $28.22 | +24.03% | 6 | Jan 10, 2025 | |
| AGL agilon health | Upgrades: Neutral | $1.75 → $2.25 | $3.52 | -36.08% | 4 | Jan 10, 2025 | |
| HIMS Hims & Hers Health | Downgrades: Sell | $24 → $25 | $49.28 | -49.27% | 7 | Jan 10, 2025 | |
| OMI Owens & Minor | Maintains: Buy | $21 → $19 | $6.22 | +197.43% | 5 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $25 | $24.52 | +1.96% | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $9.4 | $2.42 | +288.43% | 10 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $19 | $11.51 | +65.07% | 10 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $10 | $10.05 | -0.50% | 7 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $7 → $8 | $11.41 | -29.89% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1.5 → $1.25 | $4.57 | -72.65% | 5 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7 → $3.5 | $3.01 | +16.47% | 2 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $13 | $8.45 | +53.85% | 1 | Dec 11, 2019 |
Cardinal Health
Jan 10, 2025
Maintains: Neutral
Price Target: $120 → $129
Current: $127.06
Upside: +1.53%
Evolent Health
Jan 10, 2025
Maintains: Buy
Price Target: $21 → $18
Current: $10.43
Upside: +72.58%
GoodRx Holdings
Jan 10, 2025
Maintains: Buy
Price Target: $7 → $6.25
Current: $4.81
Upside: +29.94%
Health Catalyst
Jan 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $5.23
Upside: +91.20%
McKesson
Jan 10, 2025
Maintains: Buy
Price Target: $713 → $677
Current: $597.71
Upside: +13.27%
MultiPlan
Jan 10, 2025
Maintains: Neutral
Price Target: $10 → $13
Current: $29.28
Upside: -57.31%
Phreesia
Jan 10, 2025
Maintains: Buy
Price Target: $31 → $35
Current: $28.22
Upside: +24.03%
agilon health
Jan 10, 2025
Upgrades: Neutral
Price Target: $1.75 → $2.25
Current: $3.52
Upside: -36.08%
Hims & Hers Health
Jan 10, 2025
Downgrades: Sell
Price Target: $24 → $25
Current: $49.28
Upside: -49.27%
Owens & Minor
Nov 5, 2024
Maintains: Buy
Price Target: $21 → $19
Current: $6.22
Upside: +197.43%
Apr 22, 2024
Initiates: Buy
Price Target: $25
Current: $24.52
Upside: +1.96%
Apr 16, 2024
Maintains: Neutral
Price Target: $17 → $9.4
Current: $2.42
Upside: +288.43%
Feb 21, 2024
Maintains: Neutral
Price Target: $21 → $19
Current: $11.51
Upside: +65.07%
Aug 9, 2023
Maintains: Neutral
Price Target: $9 → $10
Current: $10.05
Upside: -0.50%
Aug 4, 2023
Downgrades: Sell
Price Target: $7 → $8
Current: $11.41
Upside: -29.89%
Apr 28, 2023
Maintains: Neutral
Price Target: $1.5 → $1.25
Current: $4.57
Upside: -72.65%
Nov 16, 2021
Downgrades: Neutral
Price Target: $7 → $3.5
Current: $3.01
Upside: +16.47%
Dec 11, 2019
Initiates: Outperform
Price Target: $13
Current: $8.45
Upside: +53.85%